Navigation Links
BioDrain Medical Retains KCSA Strategic Communications as Corporate Communications Counsel
Date:2/14/2013

MINNEAPOLIS, Feb. 14, 2013 /PRNewswire/ -- BioDrain Medical, Inc., (OTCQB: BIOR), producer of the FDA approved STREAMWAY® System for automated, direct-to-drain surgical fluid disposal that reduces the risk of exposure to hazardous waste, announced today that it has retained KCSA Strategic Communications (KCSA), a leading New York-based communications firm, to direct the Company's public relations program and act as its corporate communications professionals.

(Logo:  http://photos.prnewswire.com/prnh/20120517/NY09396LOGO)

KCSA has been engaged to deploy a public relations campaign designed to increase awareness of BioDrain, its products and technology, targeting the healthcare and medical device sectors, in addition to local business and leading trade publications.

Since KCSA's inception more than 40 years ago, the firm has developed a strong reputation for its work representing domestic and international companies across all industries, including medical devices, healthcare services and biotechnology. Todd Fromer and Lewis Goldberg , Managing Partners of KCSA, will lead the communications team and provide strategic counsel on financial and media communication matters.

"This engagement is coming at a critical time for our Company. We are experiencing a quick and rapid upswing in awareness about our flagship technology, the STREAMWAY System. Hospitals and healthcare groups are now proactively looking for a reliable and cost-effective solution for their fluid management requirements," said Josh Kornberg , Chief Executive Officer at BioDrain Medical.

"KCSA will lead a national awareness campaign focused on educating hospitals and healthcare facilities on how the STREAMWAY System improves operating room safety for nurses, doctors and patients with a cleaner, safer surgical fluid disposal solution that is more reliable and less expensive than the existing manual processes," concluded Mr. Kornberg.

"We believe BioDrain has a product that raises the bar for safety, efficacy and competitive pricing in a market environment that has recently become very uncertain for hospitals and other facilities that have significant fluid management needs," said Todd Fromer , Managing Partner of KCSA Strategic Communications. "Based on our experience working with dozens of healthcare companies, we believe KCSA is the right firm to help tell BioDrain's story, and we look forward to supporting their communications initiatives with targeted outreach to the healthcare industry."

About BioDrain Medical  
BioDrain Medical, Inc. has a fully automated, patented, FDA cleared, surgical fluid disposal system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. Today's manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. BioDrain's STREAMWAY System fully automates the collection, measurement and disposal of surgical fluids and is designed to result in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving Occupational State and Health Association (OSHA) and other regulatory compliance agencies' safety concerns, and 3) streamlining the efficiency of the operating room (and thereby making surgeries more profitable).

BioDrain's STREAMWAY System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come. With the installation of BioDrain's STREAMWAY System, the number of canisters can be significantly reduced. BioDrain Medical, Inc. makes the operating room and our environment safer, cleaner, and better. BioDrain products are currently being represented by independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country. For additional information, please visit: www.biodrainmedical.com.

Forward-looking Statements
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the company's ability to implement its long range business plan for various applications of its technology; the company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the company's most recent Quarterly Report on Form 10-Q and subsequent 8-K filings.

About KCSA Strategic Communications
KCSA is a fully-integrated communications agency specializing in public relations, investor relations and marketing with expertise in financial and professional services, technology, healthcare, media, energy and public services companies. Since 1969, the firm has demonstrated strategic thinking and program execution that drives results for its clients in the ever-changing communications and digital landscape. The firm's clients are its best references. For more information, please visit www.kcsa.com.

Communications Contacts: 
Todd Fromer / Samantha Wolf 
KCSA Strategic Communications 
212-896-1215 / 212-896-1220 
tfromer@kcsa.com / swolf@kcsa.com


'/>"/>
SOURCE KCSA Strategic Communications
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioDrain Medical Inc. Signs Additional Independent Distribution Agreements, Strengthening Nationwide Presence
2. BioDrain Medical, Inc. Implements Initiatives to Position Itself for Sustained Growth
3. Study Results of Dune Medicals Breast Biopsy System Presented at the Annual Meeting of the Israel Society of Breast Imaging
4. Cardinal Health To Acquire AssuraMed, Leading Direct-To-Home Medical Supplies Distributor for $2.07 Billion
5. FDA Grants 510(k) clearance for new Fluke Biomedical ESA615 Electrical Safety Analyzer
6. Michigan Supreme Court Medical Marijuana Ruling Reinforces Need For Definitive Dispensary Legislation
7. The Medical Device Market: Russia
8. Baylor University Medical Center activates Allscripts electronic health record system
9. UBM Canon MedTech Group & DuPont Partner to Create Medical Packaging Innovation, Europes New Online Community for the Medical Device Packaging Industry
10. Shiel Medical Laboratorys Oxidized LDL Triple Marker Test Uncovers Symptoms of Latent Heart Disease Better than Standard Lipid Test
11. MEMS Devices Shape Medical Industry, Microsystem Devices to Reach $6.6 billion in 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):